These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1080 related articles for article (PubMed ID: 26297223)
61. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer. Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510 [TBL] [Abstract][Full Text] [Related]
62. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related]
63. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer. Nonaka R; Miyake Y; Hata T; Kagawa Y; Kato T; Osawa H; Nishimura J; Ikenaga M; Murata K; Uemura M; Okuzaki D; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M Int J Oncol; 2015 Sep; 47(3):1097-102. PubMed ID: 26134152 [TBL] [Abstract][Full Text] [Related]
64. Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer. Almeida AL; Bernardes MV; Feitosa MR; Peria FM; Tirapelli DP; Rocha JJ; Feres O Acta Cir Bras; 2016; 31 Suppl 1():13-8. PubMed ID: 27142899 [TBL] [Abstract][Full Text] [Related]
65. Plasma microRNA-1207-5p as a Potential Biomarker for Diagnosis and Prognosis of Colorectal Cancer. Wang X; Li L; Xiao W; Xu Q Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902212 [TBL] [Abstract][Full Text] [Related]
66. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer. Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895 [TBL] [Abstract][Full Text] [Related]
67. Serum miR-372 is a Diagnostic and Prognostic Biomarker in Patients with Early Colorectal Cancer. Yu J; Jin L; Jiang L; Gao L; Zhou J; Hu Y; Li W; Zhi Q; Zhu X Anticancer Agents Med Chem; 2016; 16(4):424-31. PubMed ID: 26179262 [TBL] [Abstract][Full Text] [Related]
68. [Expression of plasma miR-106a in colorectal cancer and its clinical significance]. Zhang L; Meng L; Fan Z; Liu B; Pei Y; Zhao Z Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):354-7. PubMed ID: 24670448 [TBL] [Abstract][Full Text] [Related]
69. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853 [TBL] [Abstract][Full Text] [Related]
70. Upregulated Expression of Serum Exosomal microRNAs as Diagnostic Biomarkers of Lung Adenocarcinoma. Feng M; Zhao J; Wang L; Liu J Ann Clin Lab Sci; 2018 Nov; 48(6):712-718. PubMed ID: 30610040 [TBL] [Abstract][Full Text] [Related]
71. Identification of a circulating microRNA signature for colorectal cancer detection. Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885 [TBL] [Abstract][Full Text] [Related]
72. Plasma miRNA can detect colorectal cancer, but how early? Wikberg ML; Myte R; Palmqvist R; van Guelpen B; Ljuslinder I Cancer Med; 2018 May; 7(5):1697-1705. PubMed ID: 29573205 [TBL] [Abstract][Full Text] [Related]
73. Normalizers for microRNA quantification in plasma of patients with vulvar intraepithelial neoplasia lesions and vulvar carcinoma. Zalewski K; Misiek M; Kowalik A; Bakuła-Zalewska E; Kopczyński J; Zielińska A; Bidziński M; Radziszewski J; Góźdź S; Kowalewska M Tumour Biol; 2017 Nov; 39(11):1010428317717140. PubMed ID: 29299981 [TBL] [Abstract][Full Text] [Related]
74. Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients. Yang IP; Tsai HL; Miao ZF; Huang CW; Kuo CH; Wu JY; Wang WM; Juo SH; Wang JY J Transl Med; 2016 Apr; 14(1):108. PubMed ID: 27126129 [TBL] [Abstract][Full Text] [Related]
75. Identification of a four-microRNA panel in serum as promising biomarker for colorectal carcinoma detection. Huang G; Wei B; Chen Z; Wang J; Zhao L; Peng X; Liu K; Lai Y; Ni L Biomark Med; 2020 Jun; 14(9):749-760. PubMed ID: 32672054 [No Abstract] [Full Text] [Related]
76. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer. Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842 [TBL] [Abstract][Full Text] [Related]
77. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer. Li L; Wang A; Cai M; Tong M; Chen F; Huang L Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801 [TBL] [Abstract][Full Text] [Related]
78. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer. Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y Oncology; 2017; 92(6):360-370. PubMed ID: 28376502 [TBL] [Abstract][Full Text] [Related]
79. A Preliminary Study of the Value of Plasma microRNA-193b and Soluble Urokinase-Type Plasminogen Activator Receptor in Identifying Patients with Early-Stage Colorectal Cancer and. Liu KL; Luo JL; Wu J; Wang YD; Fan HJ Clin Lab; 2017 Nov; 63(11):1949-1953. PubMed ID: 29226653 [TBL] [Abstract][Full Text] [Related]
80. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer. Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]